1. AstraZeneca in Algeria Driven by Science, Serving Patients
Habib Bennaceur
North West Africa President
10th December 2014

2. AstraZeneca is present in Algeria since 2006
AstraZeneca in Algeria - We push the boundaries of science to deliver life-changing medicines
AstraZeneca is present in Algeria since 2006
170 employees AstraZeneca provides Algerian patients with multiple important molecules, particularly in Oncology, Cardiovascular, Respiratory and Gastrointestinal.

3. AstraZeneca as an active partner in developing people in Algeria: Our priorities
Patient support education
R&D capabilities
Local manufacturing and technology transfer
Health Care Professional skills
AstraZeneca Algeria as best place to work

4. AstraZeneca Algeria at a Glance : Opportunities and Challenges
Language
International experience
Turnover
Young population
Diversity
Education
economical and political stability
Long term presence
Scarcity & competition for talents with rising manpower costs to attract &retain the best
Lack of International experience
New people managers mainly, internally promoted

5. AstraZeneca Algeria long term commitment
Ministry of Health
Medical Scientific Societies
Patient Associations
Public Health
Patient First
- Patient support program
- Patient educators for chronic diseases
Partnering
For Scientific Leadership
- R&D (ATLANTIC, ESMAA).
- CME
- Partnerships with International academies
Employees
Great Place to Work
We engage and inspire AstraZeneca employees about our commitment to addressing urgent public health threats JV
AZ Algeria industrial Foot Print
Toll manufacturing
Collaboration with SAIDAL

6. AZ Algeria Oncology plan - Five pillars Supporting Algerian Government Strategy
Assessment of Cancer centers and send recommendation to reach international standards
Have 1 or 2 centers accredited by Karolinska or Gustavo Roussy
National cancer registries implementation
Support R&D
Implement strong screening program for Breast/Prostatic/ Colon cancer
Work on “Phakamisa” model
Kc screening and
prevention
Validate EGFR Plateform by Karolinska center
Expand diagnosis capabilities to other mutations type
Develop “Microbiologists” capabilities
Enhance Diagnosis
plateform
Assess GPs role in prevention/Screening/Follow up of the patients
Support GPs training in Oncology
Work on “Oncology Network” development
Build HCP Network & training
*based on data presented at January 2014 JP Morgan Conference.
Provide Nurses and Psychologists at home for palliative treatments
Patient support program

7. Algeria - Headquarter for North West African countries
Tinisia
Moroco
Westerne Sahara
Mauritania
Senegal
Gambia
Mali
Guinia
Cote d’Ivoire
Chad
Cent- African-Rp
Cameroom
Democ-Rp- Congo
Congo
Gabon
Niger
Benin
Togo

8. Thank you